There were 1,252 press releases posted in the last 24 hours and 429,764 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image